Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from HAE

Intellia Therapeutics Pops on CRISPR Trial Success. Does That Make NTLA Stock a Buy?

Intellia Therapeutics stock soars on promising Phase 3 results for its hereditary angioedema (HAE) candidate. But is there any further upside left in NTLA shares?

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

Haemonetics Corp (NYSE:HAE) reported upbeat earnings for the first quarter on Thursday.

3 Medical Stocks to Buy for Future Investments

3 Medical Stocks to Buy for Future Investments

The medical industry is expected to grow due to robust demand and technological advancement. Therefore, investors could consider buying fundamentally strong medical stocks, Medtronic (MDT), Haemonetics (HAE) and HealthStream (HSTM), for the long term. Keep reading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Are These 3 Medical Stocks a Safe Investment?

The future of the medical devices and equipment industry looks buoyant, given rising chronic conditions and the adoption of advanced technology. Given this backdrop, would it be prudent for investors to buy medical stocks, Terumo Corporation (TRUMY), Haemonetics Corp. (HAE), and MiMedx Group (MDXG)? Read more to find out….

3 Growth Stocks From the Medical Sector to Watch

Despite an uncertain macroeconomic environment, the medical sector should remain robust due to inelastic demand. Therefore, investors could consider adding medical stocks Medtronic (MDT), Smith & Nephew (SNN), and Haemonetics (HAE), which look poised to grow, to their watchlists. Keep reading.

4 Medical Stocks That Could Help the Health of Investors’ Portfolios

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

Raymond James Thinks Haemonetics Growth Is 'Underappreciated'

Earlier this week, Raymond James attended Haemonetics Corp's (NYSE:HAE) Investor Day, where the management team presented a new Long-Range Plan (LRP), including some upside on the profitability, outlining each business unit's positioning and pipeline. According to the analysts, the plan implies an upside to expectations, despite some conservatism and back-end weight. Raymond James rolled…

inkl

Read news from The Economist, FT, and more,
with one subscription

Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds

Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds

Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26.

Analyst Ratings For Haemonetics

Analyst Ratings For Haemonetics

Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter:

Why Haemonetics Shares Are Trading Higher Today?

Why Haemonetics Shares Are Trading Higher Today?

Haemonetics Corporation (NYSE: HAE) posted

1

People

Steve Reitmeister

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Cardinal Health Inc

Novo Nordisk AS

AmerisourceBergen Corporation

Intellia Therapeutics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play